Potential risks of compounded semaglutide: Compounded semaglutide may have the following risks depending on the pharmacy you buy from
Semaglutide decreased the risk of a five-item secondary composite kidney outcome comprising decreased eGFR and A3 albuminuria [HR 0.78 (95% CI 0.630.96)] and a five-item composite outcome based on decreased eGFR and cardiovascular death [HR 0.82 (95% CI 0.690.97)]
Before starting glutathione alongside GLP-1 therapy, discuss with your prescribing provider your oxidative stress markers, any underlying immune or kidney conditions, current medications, and treatment goals
UA levels were significantly higher in children with primary (6.71.3 mg/dL) and secondary hypertension (4.31.4 mg/dL) but not in children with white coat hypertension (3.60.7 mg/dL) compared with controls (3.60.8 mg/dL)
Symptoms may include abdominal pain, fever, and changes in bowel habits
This leads to reduced hunger and improved blood sugar control, supporting sustained weight loss
